Benzodiazepine Effects on Cognitive Decline and Dementia Risk

Summary

Benzodiazepines are widely prescribed for anxiety, insomnia and seizure disorders, but their impact on long-term cognitive health has gained increasing scrutiny. Acutely, these agents impair memory consolidation and slow processing speed, while chronically they may contribute to subtle deficits in executive function, attention and verbal recall. Observational studies have reported associations between prolonged benzodiazepine exposure and elevated dementia risk, with evidence suggesting a dose-response relationship influenced by duration of use and pharmacokinetic properties. However, confounding factors such as underlying psychiatric illness, sleep disturbance and cognitive reserve complicate causal inference. Current research seeks to disentangle reverse causation from true neurodegenerative acceleration, exploring biological mechanisms including GABAergic modulation of hippocampal neuroplasticity and reductions in neurotrophic support. The global burden of age-related cognitive decline underscores the importance of optimising prescribing practices and identifying safe alternatives for vulnerable older adults.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Benzodiazepine Effects on Cognitive Decline and Dementia Risk publication trend

The graph below shows the total number of articles in benzodiazepine effects on cognitive decline and dementia risk across all publications each year (not limited to Nature Index journals).

Technical terms

Benzodiazepine: A class of psychoactive drugs acting on GABAA receptors, used for anxiolytic, hypnotic and anticonvulsant purposes.

Cognitive reserve: The brain’s resilience to neuropathological damage, influenced by education, occupation and mental activity.

Defined daily dose (DDD): The assumed average maintenance dose per day for a drug used for its main indication in adults.

Dose-response relationship: A correlation in which changes in dose lead to predictable changes in effect or risk.

Protopathic bias: A reverse causation artefact where early symptoms of a disease lead to prescribing of a drug, falsely suggesting the drug causes the disease.

References

  1. Anterograde and Retrograde Effects of Benzodiazepines on Memory. The Scientific World JOURNAL (2006).
  2. Effects of etizolam and ethyl loflazepate on the P300 event-related potential in healthy subjects. Annals of General Psychiatry (2010).
  3. Is Long‐Term Benzodiazepine Use a Risk Factor for Cognitive Decline? Results of a Systematic Review. Journal of Addiction (2020).
  4. Associations of benzodiazepine use with cognitive ability and age-related cognitive decline. Psychological Medicine (2024).
  5. Benzodiazepine and Z-Drug Use and the Risk of Developing Dementia. The International Journal of Neuropsychopharmacology (2021).
  6. Association between Benzodiazepine Use and Dementia: A Meta-Analysis. PLOS ONE (2015).
  7. Alterations in Brain-Derived Neurotrophic Factor in the Mouse Hippocampus Following Acute but Not Repeated Benzodiazepine Treatment. PLOS ONE (2013).
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.